DAWN - Day One Biopharmaceuticals, Inc. -  [ ]

Ticker Details
Day One Biopharmaceuticals, Inc.
IPO Date: May 27, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $2.22B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.41 | 2.82%
Avg Daily Range (30 D): $0.13 | 1.19%
Avg Daily Range (90 D): $0.29 | 2.79%
Institutional Daily Volume
Avg Daily Volume: .94M
Avg Daily Volume (30 D): 5.46M
Avg Daily Volume (90 D): 3.3M
Trade Size
Avg Trade Size (Sh.): 95
Avg Trade Size (Sh.) (30 D): 208
Avg Trade Size (Sh.) (90 D): 138
Institutional Trades
Total Institutional Trades: 2,147
Avg Institutional Trade: $1.93M
Avg Institutional Trade (30 D): $3.36M
Avg Institutional Trade (90 D): $3.06M
Avg Institutional Trade Volume: .13M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.12M
Avg Closing Trade (30 D): $9.6M
Avg Closing Trade (90 D): $5.04M
Avg Closing Volume: 157.9K
 
News
Mar 18, 2026 @ 10:00 AM
XOMA Royalty Reports 2025 Financial Results and Hi...
Source: Na
Mar 12, 2026 @ 7:49 PM
Halper Sadeh LLC is Investigating Whether DAWN, SE...
Source: Halper Sadeh Llc
Mar 6, 2026 @ 1:30 PM
Servier and Day One Biopharmaceuticals announce ac...
Source: Globe Newswire
Feb 24, 2026 @ 9:00 PM
Day One Reports Fourth Quarter and Full Year 2025 ...
Source: Na
Jan 6, 2026 @ 2:02 PM
Day One Completes Acquisition of Mersana Therapeut...
Source: Globe Newswire
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-1.04 $-.21 $-1.04
Diluted EPS $-1.04 $-.21 $-1.04
Revenue $158.18M $53.72M $158.18M
Gross Profit
Net Income / Loss $-107.32M $-107.32M $-107.32M
Operating Income / Loss $-127.75M $-27.46M $-127.75M
Cost of Revenue
Net Cash Flow $72.11M $153.8M $72.11M
PE Ratio